IDEAYA Biosciences, Inc.
IDYA
$25.00
$0.140.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -331.80M | -307.08M | -274.48M | -178.12M | -153.74M |
| Total Depreciation and Amortization | 4.02M | 3.89M | 3.83M | 4.22M | 4.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.06M | 17.97M | 11.51M | 7.87M | 5.75M |
| Change in Net Operating Assets | 10.02M | 21.11M | 11.55M | 16.36M | 13.14M |
| Cash from Operations | -293.71M | -264.11M | -247.58M | -149.68M | -130.62M |
| Capital Expenditure | -3.55M | -3.86M | -3.86M | -3.59M | -3.74M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.86M | -64.91M | -498.70M | -413.80M | -342.27M |
| Cash from Investing | -91.41M | -68.77M | -502.56M | -417.39M | -346.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 307.21M | 345.18M | 668.15M | 799.24M | 549.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.40M | 9.40M | 9.40M | 16.45M | 7.05M |
| Cash from Financing | 316.61M | 354.58M | 677.55M | 815.69M | 557.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.51M | 21.70M | -72.59M | 248.62M | 80.40M |